This Week Last Year in Medtech: April 9 – 15
See what Pulse, Masimo, and C2i Genomics were up to this time last year.
Moving Toward More Accurate Pulse Oximetry
Pulse oximeters’ inaccuracy highlights digital equity issues.
MediChip Aims to Deliver Localized Cancer Treatment
The drug-delivery system developed by BioSapien is a 3D-printed biodegradable and biocompatible mesh that releases a chemotherapy drug to a specific tumor, thus eliminating adverse side effects that can happen with systemic chemotherapy procedures.
Feast Your Eyes on These Lens Trends
Analyst sees attractive growth drivers in contact lens and intraocular lens markets.
Sounds Like Masimo Investors Have a Lot of Questions
Masimo has officially bought Sound United but investors still have many questions about the deal, and the company's supply chain issues.
Using VR to Develop Spinal Implants
The VR platform helps surgeons determine how to combine three customizable components to produce implants suited to individual patients.
Fitbit Joins the AFib Detection Crowd with New Clearance
The nod allows Google’s Fitbit to more effectively compete with the Apple Watch, which has had heart monitoring capabilities since 2018.
AI-Powered Cancer Monitoring Test Launched Across Europe
C2i Genomics launches minimal residual disease test across Europe after clearing regulatory hurdles in the EU, UK, and Switzerland.
About the Author
You May Also Like